Maysam Fadaei-kenarsary, M.Phil - Kerman Neuroscience Research Center, Kerman University of Medical Sciences, I.R.Iran - PhD by Research Student n Neurosciences

Maysam Fadaei-kenarsary

M.Phil

Kerman Neuroscience Research Center, Kerman University of Medical Sciences, I.R.Iran

PhD by Research Student n Neurosciences

Kerman, Kerman | Iran (Islamic Republic of)

Main Specialties: Addiction Psychiatry, Adolescent Medicine, Biology, Clinical Neurophysiology, Pain Medicine

Additional Specialties: Addiction Neurobiology, Neurosciences, Medical Physiology

ORCID logohttps://orcid.org/0000-0002-8422-7194


Top Author

Maysam Fadaei-kenarsary, M.Phil - Kerman Neuroscience Research Center, Kerman University of Medical Sciences, I.R.Iran - PhD by Research Student n Neurosciences

Maysam Fadaei-kenarsary

M.Phil

Introduction

B.Sc. in Biology/ Golestan University, Iran 2005-2010
Animal Propensity


M.Sc. in Medical Ahvaz Jundishapur University 2010-2013
Physiology of Medical Sciences, Iran

Officer in Health Welfare Office and Clinic 2014-2015
Monitoring of Iranian Army

Counsellor Kanoon Farhangi Amoozesh 2015-2016
(Ghalamchi)

Lecturer Pouyandegan Danesh 2015-2017
High Education Center (Chalus)

PhD by Research Neuroscience Research Center 2017-now
Student Kerman University of Medical Sciences

Primary Affiliation: Kerman Neuroscience Research Center, Kerman University of Medical Sciences, I.R.Iran - Kerman, Kerman , Iran (Islamic Republic of)

Specialties:

Additional Specialties:

Research Interests:


View Maysam Fadaei-kenarsary’s Resume / CV

Education

Apr 2017
Kerman Neuroscience Research Center, Kerman University of Medical Sciences
M.Phil
1st Year in PhD by Research
Jan 2017
Kerman Neuroscience Research Center
PhD Student

Experience

Aug 2019
EZAMA final candidate in “13th International Congress on Addiction Science” Tehran 2019
1st Author
https://www.researchgate.net/profile/Meisam_Fadaei-Kenarsary2
Sep 2014
Diploma of Honour for Oral presentation in “8th International Congress on Addiction Science”
1st Author
https://scholar.google.com/citations?user=ozb8PqQAAAAJ
Sep 2013
Awarded for Best poster presentation in “7th National Congress on Addiction Science”
1st Author
https://www.researchgate.net/profile/Meisam_Fadaei-Kenarsary2

Publications

2Publications

-Reads

35Profile Views

4PubMed Central Citations

Administration of venlafaxine after chronic methadone detoxification blocks post-depression relapse in rats.

Fadaei-Kenarsary, M., et al. (2017).

Brazilian Archives of Biology and Technology

Relapse is highly prevalent after detoxification and depression. Due to the advantages of venlafaxine compared with other antidepressants, it is expected that venlafaxine administration may reduce relapse after detoxification and depression... .

View Article
January 2017

1 Citation

Impact Factor 1.064

470 Reads

Effects of Venlafaxine & Methadone Alone and in Combination with Spontaneous Morphine Withdrawal Syndrome & Pain Sensation in Rats

Fadaei-Kenarsary, M., et al. (2015).

Basic and Clinical Neuroscience

Introduction: Methadone has been used as a drug to detoxify opioid tolerance. Naloxane precipitated morphine withdrawal behaviours were attenuated by venlafaxine as an antidepressant. On the contrary, after detoxifying the opioids, spontaneous withdrawal syndrome may occur with pain sensitivity. Therefore the present study aimed to examine the effects of chronic methadone (70 mg/kg, in drinking water, 7 days), venlafaxine (80 mg/kg/day, intraperitoneally, 7 days) and their combinations with the spontaneous morphine withdrawal syndrome and pain sensitivity. Methods: Twenty eight young male Sprague-Dawley rats were randomly divided into 4 groups: control, venlafaxine treated, methadone treated and venlafaxine + methadone treated. Morphine sulfate (10 mg/kg/day, subcutaneously, 4 days) was injected to all animals. Then primary withdrawal behaviours and tail flick test were performed. The test was then followed by methadone or its vehicle administration. Second intervention was venlafaxine or its vehicle injection. Then final withdrawal behaviours and tail flick test were performed. Results: Combination of chronic methadone substitution and venlafaxine administration, significantly reduced freezing behaviour of spontaneous morphine withdrawal syndrome (p<0.01, 379±144%). Chronic methadone administration (p<0.05, 35±8% difference with venlafaxine treated group) induced hyperalgesia. A positive correlation (p=0.001, +63%) was observed between the animals final freezing scores and their response latencies to the painful stimulus. Discussion: Combination of chronic methadone and venlafaxine administrations reduces freezing withdrawal behaviour. Further investigations on analgesic interventions are needed to overcome this hyperalgesia.

View Article
January 2015

3 Citations

Impact Factor 1.548

63 Reads